The PopVax Chronicles
Subscribe
Sign in
Home
Archive
About
Potent, broadly-protective flu vaccines to protect against potential pandemic influenza viruses such as H5N1
PopVax’s influenza vaccine designs elicit as much as 250x greater antibody titer against seasonal strains than existing approved flu vaccines, as well…
Jan 3
•
Soham Sankaran
4
1
PopVax updates – NIH NIAID will conduct the Phase I trial for our COVID-19 vaccine + Gates Foundation funding for our thermostable mRNA…
We have some exciting news to share:
Dec 22, 2024
•
PopVax
2
1
The unlikely, inevitable founding of PopVax, Part I: Three meetings and six million funerals
Broadly-protective mRNA vaccines to save millions of lives
Aug 20, 2023
•
Soham Sankaran
19
The PopVax Chronicles
What it takes to develop, manufacture, test, and deploy broadly-protective mRNA vaccines
Subscribe
Links
PopVax.com
Jobs at PopVax
@PopVaxIndia on X/Twitter
PopVax on Bluesky
PopVax on Linkedin
PopVax YouTube Channel
The PopVax Chronicles
Subscribe
About
Archive
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts